ductal carcinoma in situ Researchers ID Genomic Signature to Risk Stratify Patients With Precancerous Breast Lesions In the study, presented at SABCS, researchers developed an 812-gene signature that could identify which patients with ductal carcinoma in situ need aggressive treatment. PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment Premium The test uses prognostic markers to group women based on their risk of 10-year recurrence of ductal carcinoma in situ. PreCancer Atlas Attempts to Push Precision Medicine to Early-Stage Disease Premium Cancer Moonshot-funded teams are profiling pre-cancers in an effort to establish targeted treatment, detection, and prevention methods that can be applied before cancers form. PreludeDx Receives New York State Approval for DCIS Test The company will now be able to market the test, which algorithmically weighs molecular markers and clinical information, in all 50 US states. Topographic Single-Cell Sequencing Method Yields New Insights in Breast Cancer Evolution Premium Researchers traced clonal populations with shared copy number profiles back to their location in tissue samples, confirming patterns that may have clinical relevance. Aug 6, 2015 Genomic Health Publishes Second Study on Prostate Test, Expects Medicare Reimbursement by Q4 Premium Aug 4, 2015 Genomic Health Posts Flat Q2 Revenues, Misses Wall Street Estimates Dec 12, 2014 Researchers Present Data from Second Validation Study of Genomic Health Oncotype DX DCIS Test Nov 5, 2014 Genomic Health Reports 5 Percent Revenue Growth in Third Quarter Aug 13, 2014 Genomic Health Focused on Validating, Driving Adoption of Prostate Cancer, DCIS Tests Premium Aug 7, 2014 Genomic Health Reports 11 Percent Revenue Jump in Second Quarter Sep 23, 2013 Analyst Downgrades Genomic Health to Underperform May 13, 2013 Medicare to Cover Genomic Health's Oncotype DX Breast Cancer Test for DCIS May 8, 2013 With 8 Percent Revenue Bump in Q1, Genomic Health Focus on Expanding Oncotype DX Franchise Premium Mar 13, 2013 Data Supports Oncotype DX for Predicting Recurrence in Node-Positive Cancers, Guiding Radiation Therapy Premium Feb 13, 2013 After 14 Percent Revenue Bump in 2012, Genomic Health Focusing on Market Growth, Prostate Dx Launch Premium Nov 14, 2012 Genomic Health Attributes Q3 Revenue Growth to Strong International Test Adoption Premium May 9, 2012 Genomic Health Partners with OncoMed to Grow Companion Dx, NGS Reach Premium Jan 9, 2012 Genomic Health Expanding Sales Force by 20 Percent; Starts Prostate Dx Studies Nov 2, 2011 Myriad Reports 20 Percent Q1 Revenue Growth, Rising Demand for Colorectal Cancer Test Premium Aug 10, 2011 Genomic Health Focuses on Oncotype DX Tests for DCIS and Colon Cancer for Future Growth Premium Feb 16, 2011 After Profitable Year, Genomic Health to Invest in New Products, Overseas Market, Next-Gen Sequencing Premium Sep 29, 2010 Genomic Health Updates Investors on Timeline for DCIS, Colon Cancer, Prostate Cancer Tests Premium Breaking News New Approach Identifies Candidate Causal Variants for Neuropsychiatric, Neurodevelopmental Conditions People in the News: Baylor's Thomas Caskey Dies; New Appointments at UK Biobank, CS Genetics, More In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable The Scan Omicron's Sewage Path The New York Times writes that testing sewage is helping public health officials track Omicron. IBM Sells Part of Watson Health The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm. Identifying the Right Whales The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought. Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.